Diabetes Mellitus During The Pandemic The Study The study aims to assess the effect of the pandemic on the blood glucose levels, dietary behaviors, and physical makeup of people with diabetes mellitus. It’s also done to pinpoint the components that lead to deteriorating blood glucose levels in individuals with diabetes mellitus. Introduction In early
Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia
Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia Overview In this study, the safety and tolerability of a combination of carfilzomib and vincristine, dexamethasone, asparaginase, and daunorubicin (VXLD) were assessed in children with relapsed and/or refractory acute lymphoblastic leukemia (ALL). ALL is the most common cancer diagnosed in childhood and survival for patients
Golimumab Compliance In Long-Term Arthritis Treatment
Golimumab Compliance In Long-Term Arthritis Treatment STUDY BACKGROUND Biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) are the cornerstones in treating inflammatory arthritides such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (SpA). Tumor necrosis factor-alpha (TNFα) inhibitors, including adalimumab, infliximab and golimumab are the most commonly prescribed
Medullary Thyroid Cancer and Vocal Cord Paralysis
Medullary Thyroid Cancer and vocal cord paralysis Overview Medullary thyroid cancer (MTC) is a rare form of thyroid cancer that affects only 3-5% of all thyroid cancer cases in the United States. While the prognosis for MTC is generally good, there is a chance of vocal cord paralysis (VCP) due to the
primary adenocarcinoma of the orbit: a case study
primary adenocarcinoma of the orbit: a case study Introduction Primary mucinous adenocarcinoma is an anomalous neoplasm with a tendency to frequently recur and metastasize. It is a rare neoplasm with no predisposing factors or etiology. It can often be seen throughout the body, especially in the head or neck. Symptoms include abdominal
Survival trends: pancreatic cancer in the USA
survival trends: pancreatic cancer in the USA STUDY BACKGROUND Pancreatic cancer (PC) is a devastating malignancy with a 5-year survival rate of 10%. Despite accounting for only 3% of all new cancer diagnoses, it is the third leading cause of cancer-related deaths in the US. Surgical resection is the only potentially curative
6 Strategies to Make Telehealth Work for Elderly Patients
Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. 6 Strategies to Make Telehealth Work for Elderly Patients Before the pandemic, telehealth was a relatively niche aspect of healthcare, with both doctors and patients largely unfamiliar with the technological
Pharmaceutical Industry Audit: Best Practices for GMP Compliance
Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. Pharmaceutical Industry Audit: Best Practices for GMP Compliance GMP stands for Good Manufacturing Practice regulations, which is a set of guidelines enforced by relevant agencies. These guidelines provide the foundation
nusinersen therapy for pediatric spinal muscular atrophy
nusinersen therapy for pediatric spinal muscular atrophy Study Background Spinal muscular atrophy (SMA) is an inherited motor neuron disease caused by the degeneration of anterior horn cells of the spinal cord and brainstem. SMA primarily affects babies and young children and has an incidence of 1:10,000. It is caused by a homozygous
pediatric liver transplantation: a new biological abdominal wall
pediatric liver transplantation: a new biological abdominal wall Study Background Liver transplantation (LT) is the only definitive treatment for children with advanced liver disease. Pediatric liver transplantation has evolved significantly over the past few decades, with excellent short-term and long-term survival rates. However, graft matching challenges, especially size-matched donors, remain. Also, in
